Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by investclubon Oct 07, 2019 2:44pm

367 Views

Post# 30204452

Theralase Presentation

Hey guys/gals

Theralase isn't doing a investors meeting this presentation is strictly for media and financial advisors, brockers, fund managers and the elite in financial matters. I as the head of a private investment club have been told should there be any room left then perhaps I can get in but understand this is aimed at the media and financial institutions. The release will no longer be in the shadows after Oct. 25th

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports